Capital Area Research LLC — Newport, Pennsylvania

Capital Area Research LLC is a clinical research site located in Newport, Pennsylvania, United States 17074.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Capital Area Research LLC has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease.

Sponsors: Novartis Pharmaceuticals, Amgen, Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Area Research LLC?

Capital Area Research LLC has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Area Research LLC conducted?

Capital Area Research LLC has 5 clinical trials on record, with 4 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease.

Is Capital Area Research LLC accredited by Crixeo Health?

Yes — Capital Area Research LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Capital Area Research LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.